Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
CuratioDL
CuratioDL Overview
CuratioDL provides cancer management solutions by delivering accurate diagnoses and prognoses, allowing personalized treatment for cancer patients based on deep-learning-powered pathology analysis. This pre-processing segmentation technology will allow pathologists, particularly those who are not necessarily experts in a specific field, to obtain expert-level decision support diagnosis and prognosis.
The company has an exclusive patented technology developed at Harvard University. The technology was tested successfully on 10 types of cancer malignancies and showed high validation in diagnosing types and subtypes of cancers.